Tirzepatide: Research Overview and Mechanism
Tirzepatide is a synthetic 39-residue peptide studied as a dual agonist of the GIP and GLP-1 receptors. In laboratory and preclinical research it is used to investigate incretin signaling, insulin-secretion dynamics, and energy-homeostasis endpoints. It is supplied as a lyophilized powder for research use only and is not approved for human use.
What makes Tirzepatide distinct
Tirzepatide is studied as a dual agonist that engages both the GIP (glucose-dependent insulinotropic polypeptide) receptor and the GLP-1 receptor. This dual-receptor profile distinguishes it from single-receptor incretin peptides and is the reason it is a focus of metabolic-research models.
Its structure carries aminoisobutyric acid substitutions and a C20 fatty-diacid acylation, features studied in peptide-stability research. The exact modification positions should be confirmed against the supplier Certificate of Analysis.
Pathways it is studied within
Research using Tirzepatide examines insulin secretion and glucose handling through GIP and GLP-1 signaling, alongside energy-homeostasis endpoints in preclinical models.
As a molecule, tirzepatide is an approved drug, marketed as Mounjaro following the SURPASS Phase 3 program in type 2 diabetes and as Zepbound following the SURMOUNT Phase 3 program in obesity. That is a verifiable public fact about the compound, given here as regulatory context. It is not a human-use claim for the research material on this page, which is supplied for laboratory research only and is not for human use.
Handling and documentation
Pinnacle Tirzepatide is supplied as a lyophilized powder of the 39-residue dual agonist (molecular weight near 4813.5 g/mol), whose aminoisobutyric acid substitutions and C20 fatty-diacid acylation are the stability features of research interest. Store the sealed vial at -20°C protected from light.
Reconstitute with bacteriostatic water added gently against the vial wall, avoiding the vigorous shaking that can foam and stress an acylated peptide, then refrigerate the solution. Independent HPLC and mass-spectrometry testing on each lot documents purity and confirms identity on the accompanying Certificate of Analysis; confirm the exact modification positions and salt form against it.
All products are intended strictly for in-vitro laboratory research and development use only. Not for human or veterinary use, not a drug, food, or cosmetic, and not intended to diagnose, treat, cure, or prevent any disease.